Conference Coverage

Virtual reality enters the rheumatology realm

Publish date: December 11, 2017

 

REPORTING FROM ACR 2017

Pages

Recommended Reading

Ultrasound’s value for arthralgia may be to rule out IA
MDedge Rheumatology
Prescription drug monitoring programs improve, but challenges remain
MDedge Rheumatology
What can happen if you fail to check the PDMP?
MDedge Rheumatology
FDA approves first extended-release steroid injection for OA knee pain
MDedge Rheumatology
In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Rheumatology
White House opioid panel calls for more addiction specialists
MDedge Rheumatology
Use of opioids, SSRIs linked to increased fracture risk in RA
MDedge Rheumatology
Injectable agent found to improve knee function in OA patients
MDedge Rheumatology
CMS to enlist Medicare Part D plans to combat opioid abuse
MDedge Rheumatology
New buprenorphine formulation approved for medication-assisted treatment
MDedge Rheumatology